These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 22075593)

  • 1. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.
    Onishi A; Sugiyama D; Kogata Y; Saegusa J; Sugimoto T; Kawano S; Morinobu A; Nishimura K; Kumagai S
    J Clin Microbiol; 2012 Jan; 50(1):7-15. PubMed ID: 22075593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.
    Koo S; Baden LR; Marty FM
    Clin Microbiol Infect; 2012 May; 18(5):E122-7. PubMed ID: 22404638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
    Persat F; Ranque S; Derouin F; Michel-Nguyen A; Picot S; Sulahian A
    J Clin Microbiol; 2008 Mar; 46(3):1009-13. PubMed ID: 18160456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.
    De Carolis E; Marchionni F; Torelli R; Angela MG; Pagano L; Murri R; De Pascale G; De Angelis G; Sanguinetti M; Posteraro B
    PLoS One; 2020; 15(7):e0236095. PubMed ID: 32726358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.
    White SK; Schmidt RL; Walker BS; Hanson KE
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009833. PubMed ID: 32693433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.
    He S; Hang JP; Zhang L; Wang F; Zhang DC; Gong FH
    J Microbiol Immunol Infect; 2015 Aug; 48(4):351-61. PubMed ID: 25081986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.
    Del Corpo O; Butler-Laporte G; Sheppard DC; Cheng MP; McDonald EG; Lee TC
    Clin Microbiol Infect; 2020 Sep; 26(9):1137-1143. PubMed ID: 32479781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
    Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
    Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
    Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
    Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of the (1-3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers.
    Son HJ; Sung H; Park SY; Kim T; Lee HJ; Kim SM; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    PLoS One; 2017; 12(11):e0188860. PubMed ID: 29190812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum (1 → 3)-β-D-glucan measurement as an early indicator of Pneumocystis jirovecii pneumonia and evaluation of its prognostic value.
    Held J; Koch MS; Reischl U; Danner T; Serr A
    Clin Microbiol Infect; 2011 Apr; 17(4):595-602. PubMed ID: 20673271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis.
    Lu Y; Chen YQ; Guo YL; Qin SM; Wu C; Wang K
    Intern Med; 2011; 50(22):2783-91. PubMed ID: 22082890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying optimal serum 1,3-β-D-Glucan cut-off for diagnosing Pneumocystis Jirovecii Pneumonia in non-HIV patients in the intensive care unit.
    Li YY; Chen Y; Li S; Dong R; Yang QW; Peng JM; Du B
    BMC Infect Dis; 2024 Sep; 24(1):1015. PubMed ID: 39304817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated aspergillosis following resolution of Pneumocystis pneumonia with sustained elevation of beta-glucan in an Intensive Care Unit: a case report.
    Saito T; Shime N; Itoh K; Fujita N; Saito Y; Shinozaki M; Shibuya K; Makimura K; Hashimoto S
    Infection; 2009 Dec; 37(6):547-50. PubMed ID: 19730788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients.
    Levesque E; Rizk F; Noorah Z; Aït-Ammar N; Cordonnier-Jourdin C; El Anbassi S; Bonnal C; Azoulay D; Merle JC; Botterel F
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.
    Rose SR; Vallabhajosyula S; Velez MG; Fedorko DP; VanRaden MJ; Gea-Banacloche JC; Lionakis MS
    J Infect; 2014 Sep; 69(3):278-83. PubMed ID: 24797077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of serum (1,3)-beta-d-glucan for neonatal invasive candidiasis: systematic review and meta-analysis.
    Cohen JF; Ouziel A; Matczak S; Brice J; Spijker R; Lortholary O; Bougnoux ME; Toubiana J
    Clin Microbiol Infect; 2020 Mar; 26(3):291-298. PubMed ID: 31539634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.
    Senn L; Robinson JO; Schmidt S; Knaup M; Asahi N; Satomura S; Matsuura S; Duvoisin B; Bille J; Calandra T; Marchetti O
    Clin Infect Dis; 2008 Mar; 46(6):878-85. PubMed ID: 18260755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.